nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.155	0.263	CbGbCtD
Lapatinib—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.149	0.252	CbGbCtD
Lapatinib—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.125	0.212	CbGbCtD
Lapatinib—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.101	0.171	CbGbCtD
Lapatinib—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0602	0.102	CbGbCtD
Lapatinib—TAP1—nephron tubule—focal segmental glomerulosclerosis	0.0147	0.129	CbGeAlD
Lapatinib—PIK3C2B—nephron tubule—focal segmental glomerulosclerosis	0.0138	0.121	CbGeAlD
Lapatinib—TAP1—cortex of kidney—focal segmental glomerulosclerosis	0.0126	0.11	CbGeAlD
Lapatinib—PIK3C2B—cortex of kidney—focal segmental glomerulosclerosis	0.0118	0.103	CbGeAlD
Lapatinib—PI4KB—nephron tubule—focal segmental glomerulosclerosis	0.0101	0.0879	CbGeAlD
Lapatinib—ERBB2—kidney—focal segmental glomerulosclerosis	0.00946	0.0825	CbGeAlD
Lapatinib—ERBB4—cortex of kidney—focal segmental glomerulosclerosis	0.00921	0.0803	CbGeAlD
Lapatinib—PI4KB—kidney—focal segmental glomerulosclerosis	0.00886	0.0773	CbGeAlD
Lapatinib—PI4KB—cortex of kidney—focal segmental glomerulosclerosis	0.00863	0.0753	CbGeAlD
Lapatinib—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.061	CcSEcCtD
Lapatinib—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.0559	CcSEcCtD
Lapatinib—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.0512	CcSEcCtD
Lapatinib—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.0463	CcSEcCtD
Lapatinib—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00264	0.023	CbGeAlD
Lapatinib—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00257	0.0224	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.0435	CcSEcCtD
Lapatinib—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00232	0.0202	CbGeAlD
Lapatinib—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00226	0.0197	CbGeAlD
Lapatinib—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0307	CcSEcCtD
Lapatinib—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0304	CcSEcCtD
Lapatinib—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00174	0.0152	CbGeAlD
Lapatinib—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0294	CcSEcCtD
Lapatinib—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0263	CcSEcCtD
Lapatinib—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.0014	0.0122	CbGeAlD
Lapatinib—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0223	CcSEcCtD
Lapatinib—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0221	CcSEcCtD
Lapatinib—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0221	CcSEcCtD
Lapatinib—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0217	CcSEcCtD
Lapatinib—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0216	CcSEcCtD
Lapatinib—ABCB1—kidney—focal segmental glomerulosclerosis	0.00123	0.0107	CbGeAlD
Lapatinib—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0209	CcSEcCtD
Lapatinib—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0209	CcSEcCtD
Lapatinib—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.0012	0.0105	CbGeAlD
Lapatinib—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0195	CcSEcCtD
Lapatinib—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.018	CcSEcCtD
Lapatinib—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0179	CcSEcCtD
Lapatinib—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0176	CcSEcCtD
Lapatinib—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0174	CcSEcCtD
Lapatinib—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.0173	CcSEcCtD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000924	0.00388	CbGpPWpGaD
Lapatinib—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.016	CcSEcCtD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000905	0.0038	CbGpPWpGaD
Lapatinib—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000894	0.0155	CcSEcCtD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000874	0.00367	CbGpPWpGaD
Lapatinib—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000871	0.0151	CcSEcCtD
Lapatinib—ERBB2—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000867	0.00364	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—COL4A4—focal segmental glomerulosclerosis	0.000856	0.00359	CbGpPWpGaD
Lapatinib—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00085	0.0147	CcSEcCtD
Lapatinib—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00085	0.0147	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.0146	CcSEcCtD
Lapatinib—EGFR—Focal Adhesion—COL4A4—focal segmental glomerulosclerosis	0.000827	0.00347	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000827	0.00347	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000823	0.00346	CbGpPWpGaD
Lapatinib—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000815	0.0141	CcSEcCtD
Lapatinib—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.014	CcSEcCtD
Lapatinib—TAP1—Immune System—MYH9—focal segmental glomerulosclerosis	0.000808	0.00339	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000807	0.00339	CbGpPWpGaD
Lapatinib—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000799	0.0138	CcSEcCtD
Lapatinib—ERBB2—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000796	0.00334	CbGpPWpGaD
Lapatinib—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000792	0.0137	CcSEcCtD
Lapatinib—Gefitinib—ALB—focal segmental glomerulosclerosis	0.000787	1	CrCbGaD
Lapatinib—EGFR—Signaling by PDGF—COL4A1—focal segmental glomerulosclerosis	0.000786	0.0033	CbGpPWpGaD
Lapatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—focal segmental glomerulosclerosis	0.000785	0.0033	CbGpPWpGaD
Lapatinib—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.0135	CcSEcCtD
Lapatinib—EGFR—Focal Adhesion—COL4A1—focal segmental glomerulosclerosis	0.00076	0.00319	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000752	0.00316	CbGpPWpGaD
Lapatinib—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.0129	CcSEcCtD
Lapatinib—ERBB4—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000741	0.00311	CbGpPWpGaD
Lapatinib—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.0128	CcSEcCtD
Lapatinib—ERBB2—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000732	0.00307	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.000729	0.00306	CbGpPWpGaD
Lapatinib—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000727	0.0126	CcSEcCtD
Lapatinib—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000717	0.0124	CcSEcCtD
Lapatinib—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000712	0.00299	CbGpPWpGaD
Lapatinib—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.0123	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.0122	CcSEcCtD
Lapatinib—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.0122	CcSEcCtD
Lapatinib—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.0121	CcSEcCtD
Lapatinib—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.0115	CcSEcCtD
Lapatinib—EGFR—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	0.000665	0.00279	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000658	0.00276	CbGpPWpGaD
Lapatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—focal segmental glomerulosclerosis	0.000653	0.00274	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000649	0.00272	CbGpPWpGaD
Lapatinib—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.0112	CcSEcCtD
Lapatinib—ERBB2—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000637	0.00267	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000627	0.00263	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000618	0.0026	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000606	0.00254	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000602	0.00253	CbGpPWpGaD
Lapatinib—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.0104	CcSEcCtD
Lapatinib—ERBB4—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000593	0.00249	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00059	0.00248	CbGpPWpGaD
Lapatinib—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000585	0.0101	CcSEcCtD
Lapatinib—ERBB2—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000582	0.00244	CbGpPWpGaD
Lapatinib—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00999	CcSEcCtD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000569	0.00239	CbGpPWpGaD
Lapatinib—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000558	0.00966	CcSEcCtD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000544	0.00228	CbGpPWpGaD
Lapatinib—EGFR—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.00054	0.00227	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—FN1—focal segmental glomerulosclerosis	0.00054	0.00227	CbGpPWpGaD
Lapatinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—focal segmental glomerulosclerosis	0.00054	0.00227	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00054	0.00226	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000537	0.00225	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NOS2—focal segmental glomerulosclerosis	0.000534	0.00224	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000521	0.00219	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00052	0.00218	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000518	0.00218	CbGpPWpGaD
Lapatinib—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00897	CcSEcCtD
Lapatinib—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.0089	CcSEcCtD
Lapatinib—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.00889	CcSEcCtD
Lapatinib—ERBB4—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000513	0.00215	CbGpPWpGaD
Lapatinib—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00884	CcSEcCtD
Lapatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—focal segmental glomerulosclerosis	0.0005	0.0021	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000496	0.00208	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD79A—focal segmental glomerulosclerosis	0.000489	0.00205	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000486	0.00204	CbGpPWpGaD
Lapatinib—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.00838	CcSEcCtD
Lapatinib—EGFR—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.000475	0.002	CbGpPWpGaD
Lapatinib—EGFR—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000464	0.00195	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000458	0.00192	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000455	0.00191	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000442	0.00186	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000428	0.0018	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000419	0.00176	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000416	0.00174	CbGpPWpGaD
Lapatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—focal segmental glomerulosclerosis	0.000412	0.00173	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000412	0.00173	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PIAS1—focal segmental glomerulosclerosis	0.00041	0.00172	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000404	0.00169	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000403	0.00169	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.0004	0.00168	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000399	0.00167	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—TGFB1—focal segmental glomerulosclerosis	0.000398	0.00167	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000398	0.00167	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000393	0.00165	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000389	0.00163	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000387	0.00162	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000385	0.00162	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000383	0.00161	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000371	0.00156	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000368	0.00154	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000363	0.00153	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.00036	0.00151	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—SPP1—focal segmental glomerulosclerosis	0.000359	0.00151	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000359	0.00151	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000358	0.0015	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000357	0.0015	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000354	0.00148	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	0.000352	0.00148	CbGpPWpGaD
Lapatinib—EGFR—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000349	0.00146	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.00034	0.00142	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000327	0.00137	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000314	0.00132	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000308	0.00129	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000308	0.00129	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MYH9—focal segmental glomerulosclerosis	0.000303	0.00127	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000303	0.00127	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000299	0.00125	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MYH9—focal segmental glomerulosclerosis	0.000299	0.00125	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000299	0.00125	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000291	0.00122	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000286	0.0012	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000285	0.0012	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000285	0.0012	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000281	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000281	0.00118	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—LPL—focal segmental glomerulosclerosis	0.000279	0.00117	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000277	0.00116	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000275	0.00115	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000274	0.00115	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000273	0.00114	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—LPL—focal segmental glomerulosclerosis	0.00027	0.00113	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000269	0.00113	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000265	0.00111	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000261	0.00109	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—MMP2—focal segmental glomerulosclerosis	0.000254	0.00107	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000254	0.00107	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000252	0.00106	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	0.000249	0.00105	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000247	0.00104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000243	0.00102	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000243	0.00102	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00024	0.00101	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—AGT—focal segmental glomerulosclerosis	0.000239	0.001	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000235	0.000985	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—AGT—focal segmental glomerulosclerosis	0.000231	0.000969	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00023	0.000966	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00023	0.000964	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00022	0.000923	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000219	0.000919	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000206	0.000863	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000203	0.00085	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000202	0.000847	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000198	0.000831	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000192	0.000805	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.00019	0.000797	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD79A—focal segmental glomerulosclerosis	0.000184	0.000772	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—ALB—focal segmental glomerulosclerosis	0.000183	0.00077	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD79A—focal segmental glomerulosclerosis	0.000181	0.00076	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.00018	0.000758	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—ALB—focal segmental glomerulosclerosis	0.000177	0.000743	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000151	0.000635	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00015	0.000631	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD40LG—focal segmental glomerulosclerosis	0.00015	0.000629	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000149	0.000625	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000148	0.000622	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000148	0.00062	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MYH9—focal segmental glomerulosclerosis	0.000147	0.000616	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000147	0.000615	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000144	0.000605	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000139	0.000582	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000138	0.00058	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000136	0.000571	CbGpPWpGaD
Lapatinib—ERBB2—Disease—LPL—focal segmental glomerulosclerosis	0.000136	0.00057	CbGpPWpGaD
Lapatinib—ERBB4—Disease—LPL—focal segmental glomerulosclerosis	0.000134	0.000561	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00013	0.000545	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000128	0.000537	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000126	0.000531	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000126	0.000527	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000125	0.000523	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000124	0.000519	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000123	0.000516	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000123	0.000515	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000119	0.000501	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000119	0.000498	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000118	0.000494	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000117	0.000492	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000116	0.000485	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000114	0.000478	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS2—focal segmental glomerulosclerosis	0.000106	0.000445	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000105	0.000439	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS2—focal segmental glomerulosclerosis	0.000104	0.000439	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000103	0.000434	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000103	0.000433	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	9.94e-05	0.000417	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.8e-05	0.000411	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—focal segmental glomerulosclerosis	9.76e-05	0.00041	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.66e-05	0.000405	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.51e-05	0.000399	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	9.46e-05	0.000397	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.42e-05	0.000395	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.37e-05	0.000393	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP2—focal segmental glomerulosclerosis	9.27e-05	0.000389	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.21e-05	0.000387	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.01e-05	0.000378	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SERPINE1—focal segmental glomerulosclerosis	8.93e-05	0.000375	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD79A—focal segmental glomerulosclerosis	8.89e-05	0.000373	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.87e-05	0.000372	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SERPINE1—focal segmental glomerulosclerosis	8.8e-05	0.000369	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.14e-05	0.000341	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.02e-05	0.000337	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.01e-05	0.000336	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.52e-05	0.000316	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.41e-05	0.000311	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.31e-05	0.000307	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.27e-05	0.000305	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40LG—focal segmental glomerulosclerosis	7.25e-05	0.000304	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.15e-05	0.0003	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—focal segmental glomerulosclerosis	6.97e-05	0.000292	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.66e-05	0.000279	CbGpPWpGaD
Lapatinib—EGFR—Disease—LPL—focal segmental glomerulosclerosis	6.57e-05	0.000276	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.39e-05	0.000268	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.26e-05	0.000263	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	6.2e-05	0.00026	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.16e-05	0.000259	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.12e-05	0.000257	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.11e-05	0.000257	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	6.03e-05	0.000253	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	5.74e-05	0.000241	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—focal segmental glomerulosclerosis	5.64e-05	0.000237	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.59e-05	0.000235	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—focal segmental glomerulosclerosis	5.56e-05	0.000233	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.46e-05	0.000229	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	5.31e-05	0.000223	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	5.22e-05	0.000219	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—focal segmental glomerulosclerosis	5.13e-05	0.000215	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.89e-05	0.000205	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.79e-05	0.000201	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.74e-05	0.000199	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.72e-05	0.000198	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.7e-05	0.000197	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	4.66e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.6e-05	0.000193	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	4.6e-05	0.000193	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.55e-05	0.000191	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.35e-05	0.000183	CbGpPWpGaD
Lapatinib—EGFR—Disease—SERPINE1—focal segmental glomerulosclerosis	4.32e-05	0.000181	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.23e-05	0.000178	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.19e-05	0.000176	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	4.1e-05	0.000172	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	4e-05	0.000168	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.95e-05	0.000166	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.93e-05	0.000165	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.89e-05	0.000163	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.89e-05	0.000163	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.78e-05	0.000159	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.69e-05	0.000155	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	3.68e-05	0.000154	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.63e-05	0.000153	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	3.19e-05	0.000134	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	3.15e-05	0.000132	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.02e-05	0.000127	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	2.84e-05	0.000119	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.8e-05	0.000118	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.78e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—focal segmental glomerulosclerosis	2.73e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.73e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.47e-05	0.000104	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	2.43e-05	0.000102	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	2.41e-05	0.000101	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.37e-05	9.97e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.32e-05	9.72e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.27e-05	9.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	2.09e-05	8.78e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.91e-05	8.01e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.87e-05	7.84e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.82e-05	7.65e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.71e-05	7.18e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.46e-05	6.14e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.12e-05	4.71e-05	CbGpPWpGaD
